From Nancy Davidson, MD, President of the AACR and director of the University of Pittsburgh Cancer Institute, and Margaret Foti, PhD, MD (hc), chief executive officer of the AACR
On behalf of the American Association for Cancer Research (AACR), we wish to congratulate President-elect Donald Trump on his election to the office of president of the United States. The 37,000 members of the AACR, who are laboratory researchers, physician-scientists, other health care professionals, and patient advocates, stand ready to work with the new administration to recommend innovative approaches as to how to achieve the goal of accelerating a marked reduction in cancer incidence, morbidity, and mortality.
Cancer is an enormous public health challenge worldwide, accounting for one in every seven deaths that occur around the world. In the United States alone, it is predicted that 595,690 people will die from some form of cancer in 2016. Therefore, millions of patients and their loved ones are depending on the lifesaving cancer research supported by the National Cancer Institute (NCI), National Institutes of Health (NIH), and other federal agencies, institutes, and entities, which underscores the importance for robust, sustained, and predictable annual funding increases to fuel progress against cancer.
The AACR urges President-elect Trump to stand with all Americans touched by cancer to support key elements of the Blue Ribbon Panel Report of the National Cancer Moonshot Initiative that includes 10 novel proposals for transforming the future of cancer research, treatment, and prevention in all populations.
In this unprecedented era of scientific opportunity and precision medicine, where we are witnessing extraordinary clinical outcomes by seeking targeted treatments for each individual's cancer at the genetic level, we must seize the momentum that exists in the field. Failure to capitalize upon the scientific discoveries of today is simply not an option.
Therefore, we call on President-elect Trump to rally all Americans around this cause of making cancer research a national priority so that we are able to continue to make the strides required to eradicate cancer worldwide.